EUCTR2005-003887-48-GB
Active, not recruiting
Phase 1
Randomised Controlled Trial of patient-controlled sedation for colonoscopy: Entonox versus target-controlled infusion of propofol - RCT of patient controlled sedation for colonscopy
HULL AND EAST YORKSHIRE NHS TRUST0 sites0 target enrollmentOctober 25, 2005
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- COLONOSCOPY- NO SPECIFIC MEDICAL CONDITIO
- Sponsor
- HULL AND EAST YORKSHIRE NHS TRUST
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients of both sexes undergoing elective colonoscopy will be recruited
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •1\. Patients with chronic pulmonary disease,
- •2\. History of colonic resection,
- •3\. Intolerance to any of the drugs,
- •4\. Unwilling to enter the trial
- •5\. ASA class IV,
- •6\. Allergy to soybeans, eggs,
- •7\. History of seizure disorder, sleep apnoea, or difficult intubation, a short thick neck, and inability to open mouth widely.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Randomised controlled trial of patient controlled sedation for colonoscopy: entonox vs target controlled infusion of propofolSurgery: AnalgesiaSurgeryAnalgesiaISRCTN65879800Record Provided by the NHSTCT Register - 2007 Update - Department of Health20
Recruiting
Not Applicable
Clinical Randomized Controlled Trial for the Treatment of Hashimoto's Thyroiditis by Hand Yangming Transthoracic AcupunctureHashimoto's thyroiditisITMCTR1900002701Dongzhimen Hospital, Beijing University of Traditional Chinese Medicine
Recruiting
Phase 3
A Prospective Randomized Controlled Clinical Trial of Prophylactic Cranial Irradiation in Metastatic HER-2 positive Breast Cancer.Metastatic HERDŽ positive breast cancer patientsRisk of brain metastasisPCIHER2 positiveMetastatic breast cancerTCTR20170612001Ratchadapiseksompotch research fund235
Completed
Not Applicable
A study to assess the effectiveness of Ayurvedic formulation Guduchi Ghan vati in Covid-19 casesCTRI/2020/07/026840Directorate of AYUSH Government of Madhya Pradesh30
Completed
Phase 2
To observe the effect of Ayurvedic medicine (Ashwagandha and Shunti) for the treatment of COVID-19Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/08/027224Central Council for Research in Ayurvedic Sciences New Delhi48